Brain Health
Stroke, TIA, dementia, and brain health prevention.
Evidence-based content on metabolic health, chronic disease, and everyday health decisions — no fluff, no sensationalism.
Browse All GuidesCurated topic hubs — rotates weekly
Stroke, TIA, dementia, and brain health prevention.
Weight, insulin resistance, GLP-1s, and cardiometabolic risk.
Aging biology, lifespan heritability, and longevity debates.
Outbreaks, vaccines, and practical infectious disease guidance.
New cardiology evidence suggests we’re missing high-risk patients—and treating too late.
Demand for peptide therapy is exploding in the U.S., but regulation is still trying to define what’s legal, safe, and real medicine.
Utah is piloting AI-driven prescription renewals for chronic medications. The idea could improve access and reduce friction, but it also raises important questions about safety, accountability, transparency, and the loss of clinical touchpoints.
Most GLP-1 patients stop within a year. Here's why adherence — not efficacy — is the defining challenge in metabolic therapy.
A new BMJ Medicine study suggests stopping GLP-1 drugs may quickly erase their cardiovascular benefits.
Recently updated health guides
A clear explanation of ApoB vs LDL cholesterol, and why particle number may be more important than cholesterol levels.
A complete guide to brain health, including stroke recognition, TIA, dementia, and long-term prevention.
How heart disease risk is assessed today, and why newer tools like CAC, ApoB, and Lp(a) are changing prevention.
A guide to CAC scoring, how it works, and when it helps refine heart disease risk.
A guide to dementia, including early symptoms, causes, and how risk can be reduced.
A complete guide to understanding heart disease risk, testing options, and prevention strategies.
What Lp(a) is, why it matters, and who should get tested.
A clear guide to TIA (mini-stroke), why it matters, and what to do after symptoms.